生长激素释放激素 comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-06-17. Where a claim depends on a specific study, the study is described rather than over-claimed.
Several related peptides act on the same receptor, including sermorelin, a shorter GHRH fragment, and modified analogs such as CJC-1295 and modified GRF(1-29) that are common in research settings rather than approved products. Tesamorelin differs from growth hormone itself in that it acts upstream, prompting the pituitary to release the hormone through physiological signaling rather than supplying it directly. Terminology in the literature distinguishes GHRH analogs, growth hormone secretagogues, and recombinant growth hormone, although popular discussion often blurs these categories together. Precise naming matters when comparing study results.
Tesamorelin is a synthetic peptide of 44 amino acids that reproduces the sequence of human growth hormone-releasing hormone (GHRH) and carries a trans-3-hexenoyl group on its N-terminal tyrosine. That small fatty-acid modification blocks cleavage by dipeptidyl peptidase-4, the enzyme that rapidly degrades native GHRH in plasma. The result is a molecule with a longer circulating half-life than the natural hormone while retaining the same receptor target. It is supplied as a lyophilized powder for reconstitution and belongs to the broader class of GHRH analogs studied for effects on pituitary growth hormone secretion.
Development work on the compound, originally designated TH9507, focused on conditions in which reduced growth hormone signaling is thought to contribute to altered body composition. The United States Food and Drug Administration approved it in 2010 for the treatment of excess visceral abdominal fat in adults with human immunodeficiency virus infection and lipodystrophy. Later research examined other populations, including adults with mild cognitive impairment, where a large trial did not meet its primary endpoints. This mixed record illustrates how a single mechanism can produce clear effects in one setting and inconclusive results in another.
Tesamorelin occupies a narrow position among agents that act on the growth hormone axis. Unlike growth hormone itself, which is given as replacement, it stimulates the pituitary to release the hormone in pulses, so the downstream increase in insulin-like growth factor 1 depends on intact somatotroph function. Other peptides in the same family include shorter GHRH fragments and synthetic secretagogues with different stability profiles. Several points remain unresolved, including whether the reduction in visceral fat translates into fewer cardiovascular events, what happens to metabolic markers after long-term use, and how the drug compares with lifestyle or surgical approaches.
Tesamorelin is a synthetic peptide that belongs to the growth hormone-releasing hormone family and contains the same forty-four amino acid sequence as endogenous GHRH, extended at the amino terminus by a trans-3-hexenoyl group. That small fatty acid modification protects the peptide from rapid cleavage by dipeptidyl peptidase-4, the enzyme that shortens the half-life of native GHRH to only a few minutes. Chemically the compound is produced by solid-phase peptide synthesis, purified by chromatography, and supplied as a sterile lyophilized powder for reconstitution.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic 44-residue GHRH analog | Sequence matches human GHRH(1-44); differs only at the N-terminus |
| Nominal molecular mass | Approximately 5,136 Da (free base) | Small variation arises from counterion and salt form |
| Appearance | White to off-white lyophilized powder | Supplied in single-use vials intended for reconstitution |
| Solubility class | Freely soluble in water | Practically insoluble in nonpolar organic solvents |
| Typical storage | 2 to 8 degrees Celsius, protected from light | Reconstituted material is handled according to label instructions |
Clinical interest in tesamorelin arose from the need to address visceral adiposity in people living with HIV. Antiretroviral therapy improved survival but was associated in some patients with central fat accumulation, altered lipid profiles, and metabolic complications. This condition, often called HIV-associated lipodystrophy, involves excess visceral adipose tissue that is difficult to manage through diet and exercise alone. Investigators evaluated tesamorelin because GHRH analogs can stimulate growth hormone secretion and influence fat distribution without direct liposuction or invasive procedures.
A Phase 3 program led to regulatory approval in the United States in 2010 for reduction of excess visceral abdominal fat in adults with HIV and lipodystrophy. Subsequent studies examined effects on liver fat, muscle area, and metabolic markers, with mixed findings for some endpoints. Long-term cardiovascular outcomes and effects on mortality remain uncertain because most trials were relatively short and focused on imaging-based fat measurements. Use in populations without HIV has been studied experimentally but is not part of the approved indication.
Tesamorelin is a synthetic analog of growth hormone-releasing hormone, a peptide hormone produced by the hypothalamus. The molecule retains the 44-amino-acid sequence of human GHRH and carries a trans-3-hexenoyl modification at its N-terminus. This modification increases resistance to enzymatic degradation and extends the peptide's functional stability relative to native GHRH. The compound is supplied as a lyophilized powder for reconstitution and subcutaneous administration in clinical settings. Its development code was TH9507, and it belongs to the GHRH analog class. It is not a growth hormone product; instead, it acts upstream to stimulate endogenous growth hormone release.
特沙莫瑞林是一种合成肽，其序列与人生长激素释放激素的 44 个氨基酸形式相关。它在 N 端带有反式-3-己烯酰基修饰，这一改动可减缓二肽基肽酶 IV 的降解。该化合物属于生长激素释放激素受体激动剂，可刺激垂体释放生长激素。研究文献通常将其归入合成肽类药物，而非小分子化合物。
监管记录显示，特沙莫瑞林于 2010 年在美国首次获得批准，用于人类免疫缺陷病毒感染相关的脂肪营养不良患者。批准依据来自降低内脏脂肪的临床试验，而非体重或瘦体重的普遍改善。后续出现了不同制剂版本，但其核心适应症保持一致。关于长期心血管结局和死亡率影响，现有证据仍不充分。
In 1910, Hahn was appointed professor by the Prussian Minister of Culture and Education, August von Trott zu Solz. Two years later, Hahn became head of the Radioactivity Department of the newly founded Kaiser Wilhelm Institute for Chemistry (KWIC) in Berlin-Dahlem (in what is today the Hahn-Meitner-Building of the Free University of Berlin). This came with an annual salary of 5,000 marks (equivalent to €29,000 in 2021). In addition, he received 66,000 marks in 1914 (equivalent to €369,000 in 2021) from Knöfler for the mesothorium process, of which he gave 10 per cent to Meitner. The new institute was inaugurated on 23 October 1912 in a ceremony presided over by Kaiser Wilhelm II. The Kaiser was shown glowing radioactive substances in a dark room. The move to new accommodation was fortuitous, as the wood shop had become heavily contaminated by radioactive liquids that had been spilt, and radioactive gases that had vented and then decayed and settled as radioactive dust, making sensitive measurements impossible. To ensure that their clean new laboratories stayed that way, Hahn and Meitner instituted strict procedures. Chemical and physical measurements were conducted in different rooms, people handling radioactive substances had to follow protocols that included not shaking hands, and rolls of toilet paper were hung next to every telephone and door handle. Strongly radioactive substances were stored in the old wood shop, and later in a purpose-built radium house on the institute grounds.
However, in a preprint study, Carnegie Mellon University researchers tested the behavior of agents in a simulated software company and found that none of the agents could complete a majority of the tasks assigned to them. Other researchers had similar findings with Devin AI and other agents in both formal business settings and freelance work. In June 2025, CNN argued that CEOs's statements on AI replacing their employees were a strategy to "[keep] workers working by making them afraid of losing their jobs." Tech companies have pressured employees to use generative AI models in their work, including AI coding agents. Brian Armstrong, the CEO of Coinbase, fired several employees who did not. Some business leaders have replaced some of their employees with agents, but have said that the agents would need more supervision than those employees. In October 2025, Futurism questioned whether Amazon's previously announced efforts to replace parts of its workforce with generative AI and AI agents could have led to the October 2025 outage of Amazon Web Services. Large technology companies such as Salesforce, Klarna and IBM announced layoffs in 2025, replacing hundreds of their employees in human resources or customer service with AI agents. However, Klarna later rehired several human employees. Yoshua Bengio warned at the 2025 World Economic Forum that "all of the catastrophic scenarios with AGI or superintelligence happen if we have agents". Financial authorities have warned that more complex and autonomous "agentic" AI could become a channel for systemic risk in finance.
Thus, in the presence of the inhibitor, the enzyme's effective Km and Vmax become (α/α')Km and (1/α')Vmax, respectively. However, the modified Michaelis-Menten equation assumes that binding of the inhibitor to the enzyme has reached equilibrium, which may be a very slow process for inhibitors with sub-nanomolar dissociation constants. In these cases the inhibition becomes effectively irreversible, hence it is more practical to treat such tight-binding inhibitors as irreversible (see below). The effects of different types of reversible enzyme inhibitors on enzymatic activity can be visualised using graphical representations of the Michaelis–Menten equation, such as Lineweaver–Burk, Eadie-Hofstee or Hanes-Woolf plots. An illustration is provided by the three Lineweaver–Burk plots depicted in the Lineweaver–Burk diagrams figure. In the top diagram the competitive inhibition lines intersect on the y-axis, illustrating that such inhibitors do not affect Vmax. In the bottom diagram the non-competitive inhibition lines intersect on the x-axis, showing these inhibitors do not affect Km. However, since it can be difficult to estimate Ki and Ki' accurately from such plots, it is advisable to estimate these constants using more reliable nonlinear regression methods.
== Tolerance and overdoses == Fatal opioid overdose typically occurs due to bradypnea, hypoxemia, and decreased cardiac output (hypotension occurs due to vasodilation, and bradycardia further contributes to decreased cardiac output). A potentiation effect occurs when opioids are combined with ethanol, benzodiazepines, barbiturates, or other central depressants which can result in rapid loss of consciousness and an increased risk of fatal overdose. Substantial tolerance to respiratory depression develops quickly, and tolerant individuals can withstand larger doses. However, tolerance to respiratory depression is quickly lost during withdrawal and may be completely reversed within a week. Many overdoses occur in people who return to their previous dose after having lost their tolerance following cessation of opioids. This puts addicts who receive medical treatment for opioid addiction at great risk of overdose when they are released, as they may be particularly vulnerable to relapse. Less commonly, massive overdoses have been known to cause circulatory collapse from vasodilation and bradycardia. Opioid overdoses can be rapidly reversed through the use of opioid antagonists, naloxone being the most widely used example. Opioid antagonists work by binding competitively to μ-opioid receptors and displacing opioid agonists. Additional doses of naloxone may be necessary and supportive care should be given to prevent hypoxic brain injury by monitoring vital signs.
=== 1 April === A court in Kyiv ordered the house arrest of Metropolitan Pavlo (born Petro Lebid) of the Ukrainian Orthodox Church (Moscow Patriarchate) for allegedly supporting the Russian invasion of Ukraine. He was later taken under police custody on 14 July. Russia assumed the presidency of the UN Security Council for the month, a role in which Russia was able to maneuver meetings on Ukraine to portray the US and other Western countries as making false accusations against Russia.
Sources: en.wikipedia.org
Wandering blue tangs are often chased by other fish, and also visit cleaning stations more often than those in the other modes. Wandering is found most often in the reef back zone (enclosed region with irregular patches of algae, rock and sand) and during the morning. With an increase in conspecific population density, blue tang individuals become more territorial. Small, juvenile blue tangs are territorial, but the incidence of territoriality in the larger classes decreases. However, in these fish, schooling and wandering increases.
=== Morphology === Polymer morphology generally describes the arrangement and microscale ordering of polymer chains in space. The macroscopic physical properties of a polymer are related to the interactions between the polymer chains.
== Public reception == The discovery of Lindow Man in 1984 at Lindow Moss in Cheshire, England, received worldwide news coverage. Newspapers adopted the nickname "Pete Marsh", while scientists investigating his remains called him Lindow Man. In April 1985, a documentary about the investigation in the BBC television series Q.E.D. was watched by more than 10 million people. His first temporary exhibition at Manchester Museum in 1987 attracted up to 2,000 visitors a day. During the exhibition, local resident Barbara O'Brien led a campaign for his remains to stay permanently in North West England. The campaign gained support from local members of Parliament and attracted coverage in local and national newspapers. In November 1987, pupils at Lindow Primary School recorded O'Brien's song, "Lindow Man We Want You Back Again". The campaign was unsuccessful, and the British Museum retained the remains. The Manchester Museum exhibition of 2008–2009 presented different perspectives on Lindow Man through personal accounts from people involved in his discovery and study, museum curators, a local resident and a pagan contributor. According to museum curator Bryan Sitch, public responses were mixed but broadly favourable. Some visitors questioned the inclusion of a pagan viewpoint alongside scientific interpretations, while others criticised the design or wanted more factual information. Visitors left thousands of comment cards and personal offerings, which the museum collected for further study. The exhibition also contributed to debate about whether human remains should be displayed.
It could be used to detect trace contaminants in environmental samples, to identify drugs in a case of overdose, and to measure drug metabolites. After the United States Environmental Protection Agency (EPA) was established in 1970, it became a major customer for Finnigan's GC/MS. The EPA surveyed possible monitoring instruments for use in monitoring organic pollutants. Speed, cost, and performance were all important concerns. The target machine was projected as having the ability to scan for pesticides with a resolving power of 1,000 to 10,000, across a broad range of 10 nanograms to one microgram. A computer-controlled system was desirable. An international array of instruments were reviewed, of which only two used quadrupole technology. An expert panel recommended Finnigan's quadrupole GC/MS to the EPA for further evaluation, and twenty Finnigan Model 1015/System 150 instruments were ordered soon after by the EPA. Finnigan published a 1979 study, based on users, indicating that in spite of the high initial cost of the equipment, the Finnigan GC/MS was reliable and cost-effective. By 1979, the Finnigan GC/MS was the preferred instrument at the EPA for the analysis of environmental pollutants in water and wastewater. The models most generally used were Finnigan Corporation's 1015 and 3000 series of quadrupole mass spectrometers with a data system based on DEC's PDP-8 computers. The EPA also based its instruction manuals and standards for environmental testing on the Finnigan GC/MS, publishing the results in the Federal Register in 1979.
Sources: en.wikipedia.org
It is a synthetic peptide built from 44 amino acids arranged in the same order as human growth hormone-releasing hormone. A short fatty-acid chain, described as a trans-3-hexenoyl group, is attached to the first amino acid. The finished molecule is formulated as a sterile powder that is dissolved before use.
No. It is a releasing-factor analog that signals the pituitary gland to secrete growth hormone, whereas recombinant growth hormone is the hormone itself administered directly. The two are chemically distinct and act at different points in the same endocrine pathway. This distinction is often lost in informal discussion.
Native growth hormone-releasing hormone is broken down within minutes by dipeptidyl peptidase-4 in the bloodstream. Adding the hexenoyl group at the N-terminus shields the peptide from that enzyme. The modification does not change the receptor it targets, only how long the peptide survives in circulation.
It is a laboratory-made peptide of forty-four amino acids whose sequence matches human growth hormone-releasing hormone, with a modified amino terminus. The modification is a short unsaturated fatty acid chain attached to the first residue. This change slows enzymatic breakdown and lengthens the time the peptide stays active in circulation.